summary
Introduced
01/11/2021
01/11/2021
In Committee
05/19/2021
05/19/2021
Crossed Over
04/19/2021
04/19/2021
Passed
05/20/2021
05/20/2021
Dead
Signed/Enacted/Adopted
09/25/2021
09/25/2021
Introduced Session
2021 Legislative Measures
Bill Summary
Limits cost-sharing for health benefit plan coverage of insulin prescribed for treatment of diabetes. Limits cost-sharing for health benefit plan coverage of insulin prescribed for treatment of diabetes.
AI Summary
This bill limits the cost-sharing or out-of-pocket costs that a health benefit plan in Oregon can require for a 30-day or 90-day supply of insulin prescribed for the treatment of diabetes. Specifically, it caps the maximum cost-sharing at $75 for a 30-day supply and $225 for a 90-day supply, and requires the Department of Consumer and Business Services to annually adjust these maximums based on changes in the Consumer Price Index. The bill also prohibits health benefit plans from applying a deductible to this insulin coverage. However, it does not prohibit plans from using a drug formulary or other utilization review protocols for prescription drug coverage. This bill applies to health benefit plans issued, renewed, or extended on or after January 1, 2022.
Committee Categories
Health and Social Services
Sponsors (28)
Sheri Schouten (D)*,
David Smith (R)*,
Teresa Alonso Leon (D),
Wlnsvey Campos (D),
Julie Fahey (D),
Lew Frederick (D),
Dacia Grayber (D),
Diego Hernandez (D),
Paul Holvey (D),
Zach Hudson (D),
Bill Kennemer (R),
Gary Leif (R),
James Manning (D),
Mark Meek (D),
Nancy Nathanson (D),
Courtney Neron Misslin (D),
Rob Nosse (D),
Deb Patterson (D),
Katherine Pham (D),
Karin Power (D),
Rachel Prusak (D),
Jeff Reardon (D),
Lisa Reynolds (D),
Ricki Ruiz (D),
Tawna Sanchez (D),
Janeen Sollman (D),
Andrea Valderrama (D),
Anna Williams (D),
Last Action
Chapter 160, (2021 Laws): Effective date January 01, 2022. (on 09/25/2021)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...